Alexza Pharma (ALXA) Short Interest Rises into Adasuve Panel Vote
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Join SI Premium – FREE
Alexza Pharmaceuticals (Nasdaq: ALXA) is currently halted following the EMA issuing a positive recommendation for Adasuve.
Traders might want to brace for quite a ride. Short interest is 2,421,339 as of November 30th, or about 16.4 percent of float. The number is up from 2,176,336 at November 15th and 1,964,769 on October 31st.
Days to cover, however, moved from 7.53 at the end of October to just 3.36 at the end of November.
Shares closed Thursday up 5.9 percent. Looking at a one-year chart, Alexza might see activity if it gets above the key $6 level, a point it gapped below last April.
Traders might want to brace for quite a ride. Short interest is 2,421,339 as of November 30th, or about 16.4 percent of float. The number is up from 2,176,336 at November 15th and 1,964,769 on October 31st.
Days to cover, however, moved from 7.53 at the end of October to just 3.36 at the end of November.
Shares closed Thursday up 5.9 percent. Looking at a one-year chart, Alexza might see activity if it gets above the key $6 level, a point it gapped below last April.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- PowerSchool Holdings, Inc. (PWSC) Mentioned Cautiously at Spruce Point
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
